GLPwatch
Saxenda vs Xultophy
Drug comparison
Last updated 2026-05-28 15:46 UTCSaxenda and Xultophy both contain the same active ingredient, liraglutide, and are given as injections under the skin. Saxenda is FDA-approved to treat obesity, while Xultophy is approved for type 2 diabetes. Both are made by Novo Nordisk, but they are used for different medical conditions.
AI summary of the sources below.
| Saxenda | Xultophy | |
|---|---|---|
| Active ingredient | liraglutide | liraglutide |
| Manufacturer | novo-nordisk | novo-nordisk |
| Route | subcutaneous injection | subcutaneous injection |
| FDA-approved for | obesity | type 2 diabetes |
| Label updated | 2026-02-25 | 2025-10-14 |